12-Jun-2026
MetLife Launches New Deferred Payment Option for Non-Physical Injury Claims
Business Wire (Thu, 11-Jun 9:00 AM ET)
World Cup 2026 Is Coming. These Hotel, Travel, and Food Stocks Could Benefit
TipRanks (Tue, 9-Jun 5:32 AM ET)
MetLife CFO to Speak at Morgan Stanley US Financials Conference
Business Wire (Wed, 3-Jun 4:15 PM ET)
MetLife and Highlights Launch Free Soccer-Themed Digital Magazine to Help Boost Kid's Confidence
Business Wire (Tue, 2-Jun 9:05 AM ET)
MetLife Expands Guaranteed Retirement Income Offering with Innovative Flexible Annuity Option
Business Wire (Thu, 28-May 9:00 AM ET)
MetLife Declares Second Quarter 2026 Preferred Stock Dividends
Business Wire (Fri, 15-May 4:15 PM ET)
Business Wire (Tue, 12-May 9:00 AM ET)
MetLife CFO John McCallion Provides First Quarter 2026 Financial Update Video
Business Wire (Wed, 6-May 4:20 PM ET)
MetLife Announces 1Q 2026 Results
Business Wire (Wed, 6-May 4:15 PM ET)
VanEck Enters CLO Equity Market with First Interval Fund, Sub-advised by PineBridge
PRNewswire (Fri, 1-May 8:00 AM ET)
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
Metlife trades on the NYSE stock market under the symbol MET.
As of June 12, 2026, MET stock price climbed to $88.84 with 2,920,420 million shares trading.
MET has a beta of 0.84, meaning it tends to be less sensitive to market movements. MET has a correlation of 0.19 to the broad based SPY ETF.
MET has a market cap of $57.16 billion. This is considered a Large Cap stock.
Last quarter Metlife reported $20 billion in Revenue and $2.42 earnings per share. This beat revenue expectation by $302 million and exceeded earnings estimates by $.15.
In the last 3 years, MET traded as high as $89.44 and as low as $52.97.
The top ETF exchange traded funds that MET belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
MET has underperformed the market in the last year with a return of +15.5%, while SPY returned +24.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in MET shares. However, MET has outperformed the market in the last 3 month and 2 week periods, returning +27.8% and +8.4%, while SPY returned +9.9% and -1.7%, respectively. This indicates MET has been having a stronger performance recently.
MET support price is $86.40 and resistance is $88.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MET shares will trade within this expected range on the day.